144 related articles for article (PubMed ID: 16312575)
1. Clinical experience with lower doses of cefotaxime in hospitalized patients with serious infections.
Shah A; Madhavan T; Drelichman V; Price J
J Chemother; 1989 Jul; 1(4 Suppl):650-1. PubMed ID: 16312575
[No Abstract] [Full Text] [Related]
2. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections.
Sen RA; Keaney MG; Ganguli LA
J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576
[No Abstract] [Full Text] [Related]
3. Clinical efficacy of cefotaxime in two different periods.
Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
[No Abstract] [Full Text] [Related]
4. Oral and i.v.-to-p.o. switch antibiotic therapy of hospitalized patients with serious infections.
Cunha BA
Scand J Infect Dis; 2008; 40(11-12):1004-6. PubMed ID: 18821274
[No Abstract] [Full Text] [Related]
5. Cefotaxime in a single daily dose in lower urinary tract infections.
Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
[No Abstract] [Full Text] [Related]
6. A comparison of ceftriaxone (1 g single dose) versus cefotaxime (three 1 g doses) for gynecologic and obstetric infections.
Gerstner GJ
J Chemother; 1989 Jul; 1(4 Suppl):884-6. PubMed ID: 16312686
[No Abstract] [Full Text] [Related]
7. A retrospective analysis of twice-daily cefotaxime compared to conventional therapy for the treatment of infections in a USA hospital.
Burke JP; Pestotnik SL; Classen DC; Lloyd JF
Diagn Microbiol Infect Dis; 1995; 22(1-2):167-9. PubMed ID: 7587034
[TBL] [Abstract][Full Text] [Related]
8. In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage.
Firsov AA
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():406-9. PubMed ID: 1820913
[TBL] [Abstract][Full Text] [Related]
9. Doripenem (Doribax)--a new parenteral carbapenem.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
[No Abstract] [Full Text] [Related]
10. Cefotaxime therapy for serious infections.
Tanphaichitra D; Wanvarie S; Srimuang S
J Med Assoc Thai; 1984 Feb; 67(2):108-10. PubMed ID: 6330259
[No Abstract] [Full Text] [Related]
11. [Clinical and microbiological study of the use of cefotaxime in a series of predominantly pediatric cases].
Fabbri A; Marazzi MG; Manno G; Giacchino R
Minerva Pediatr; 1983 Mar; 35(5):251-6. PubMed ID: 6304483
[No Abstract] [Full Text] [Related]
12. Further observations of the role of timentin in clinical practice.
Shah A; Madhavan T; Drelichman V; Price J
J Chemother; 1989 Jul; 1(4 Suppl):656-7. PubMed ID: 16312578
[No Abstract] [Full Text] [Related]
13. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
[TBL] [Abstract][Full Text] [Related]
14. Oral antibiotic therapy of serious systemic infections.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1197-222. PubMed ID: 17116444
[TBL] [Abstract][Full Text] [Related]
15. Imipenem in the treatment of infections at different sites.
Peralta S; Di Marco P; Tinnirello D; D'Aiello G; Ribisi La Spina AM; Scarsi C; Rotolo G; Pirrotta P; Citarrella P
J Chemother; 1989 Jul; 1(4 Suppl):636-7. PubMed ID: 16312568
[No Abstract] [Full Text] [Related]
16. Ampicillin and cefotaxime as a risk factor of neonatal death.
Lee PI
Pediatrics; 2006 May; 117(5):1857; author reply 1857-8. PubMed ID: 16651354
[No Abstract] [Full Text] [Related]
17. Serious, life-threatening infections: results with pefloxacin.
Gargalianos P; Lelekis M; Lanaras L; Karakatsani E; Tsouroulas P; Kosmidis J
J Chemother; 1989 Jul; 1(4 Suppl):672-3. PubMed ID: 16312586
[No Abstract] [Full Text] [Related]
18. Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion.
Bertels RA; Semmekrot BA; Gerrits GP; Mouton JW
Infection; 2008 Oct; 36(5):415-20. PubMed ID: 18791659
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and clinical efficacy of cefotaxime for the treatment of septicaemia in dogs.
Sumano H; Gutierrez L; Ocampo L
Acta Vet Hung; 2004; 52(1):85-95. PubMed ID: 15119790
[TBL] [Abstract][Full Text] [Related]
20. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
